AustralieFrV1, PascalFrancis, Curation, bibRecord, 005877

Updated Treatment Algorithm of Pulmonary Arterial Hypertension

Identifieur interne : 005877 ( PascalFrancis/Curation ); précédent : 005876; suivant : 005878

Updated Treatment Algorithm of Pulmonary Arterial Hypertension

Auteurs : Nazzareno Galie [Italie] ; Paul A. Corris [Royaume-Uni] ; Adaani Frost [États-Unis] ; Reda E. Girgis [États-Unis] ; John Granton [Canada] ; ZHI CHENG JING [République populaire de Chine] ; Walter Klepetko [Autriche] ; Michael D. Mcgoon [États-Unis] ; Vallerie V. Mclaughlin [États-Unis] ; Ioana R. Preston [États-Unis] ; Lewis J. Rubin [États-Unis] ; Julio Sandoval [Mexique] ; Werner Seeger [Allemagne] ; Anne Keogh [Australie]

Source :

Journal of the American College of Cardiology [ 0735-1097 ] ; 2013.

RBID : Pascal:14-0036896

Descripteurs français

Pascal (Inist)
- Hypertension artérielle pulmonaire, Pathologie de l'appareil circulatoire, Traitement, Algorithme, Arbre décision, Artère, Appareil circulatoire, Cardiologie.

English descriptors

KwdEn :
- Algorithm, Artery, Cardiology, Cardiovascular disease, Circulatory system, Decision tree, Pulmonary hypertension, Treatment.

Abstract

The demands on a pulmonary arterial hypertension (PAH) treatment algorithm are multiple and in some ways conflicting. The treatment algorithm usually includes different types of recommendations with varying degrees of scientific evidence. In addition, the algorithm is required to be comprehensive but not too complex, informative yet simple and straightforward. The type of information in the treatment algorithm are heterogeneous including clinical, hemodynamic, medical, interventional, pharmacological and regulatory recommendations. Stakeholders (or users) including physicians from various specialties and with variable expertise in PAH, nurses, patients and patients' associations, healthcare providers, regulatory agencies and industry are often interested in the PAH treatment algorithm for different reasons. These are the considerable challenges faced when proposing appropriate updates to the current evidence-based treatment algorithm. The current treatment algorithm may be divided into 3 main areas: 1) general measures, supportive therapy, referral strategy, acute vasoreactivity testing and chronic treatment with calcium channel blockers; 2) initial therapy with approved PAH drugs; and 3) clinical response to the initial therapy, combination therapy, balloon atrial septostomy, and lung transplantation. All three sections will be revisited highlighting information newly available in the past 5 years and proposing updates where appropriate. The European Society of Cardiology grades of recommendation and levels of evidence will be adopted to rank the proposed treatments.

A01	`01`	`1`		`@0 0735-1097`
A02	`01`			`@0 JACCDI`
A03		`1`		`@0 J. Am. Coll. Cardiol.`
A05				`@2 62`
A06				`@2 25 @3 SUPD`
A08	`01`	`1`	`ENG`	`@1 Updated Treatment Algorithm of Pulmonary Arterial Hypertension`
A09	`01`	`1`	`ENG`	`@1 Updates in Pulmonary Hypertension: Proceedings of the 5th World Symposium on Pulmonary Hypertension`
A11	`01`	`1`		`@1 GALIE (Nazzareno)`
A11	`02`	`1`		`@1 CORRIS (Paul A.)`
A11	`03`	`1`		`@1 FROST (Adaani)`
A11	`04`	`1`		`@1 GIRGIS (Reda E.)`
A11	`05`	`1`		`@1 GRANTON (John)`
A11	`06`	`1`		`@1 ZHI CHENG JING`
A11	`07`	`1`		`@1 KLEPETKO (Walter)`
A11	`08`	`1`		`@1 MCGOON (Michael D.)`
A11	`09`	`1`		`@1 MCLAUGHLIN (Vallerie V.)`
A11	`10`	`1`		`@1 PRESTON (Ioana R.)`
A11	`11`	`1`		`@1 RUBIN (Lewis J.)`
A11	`12`	`1`		`@1 SANDOVAL (Julio)`
A11	`13`	`1`		`@1 SEEGER (Werner)`
A11	`14`	`1`		`@1 KEOGH (Anne)`
A12	`01`	`1`		`@1 GALIE (Nazzareno) @9 ed.`
A12	`02`	`1`		`@1 SIMONNEAU (Gerald) @9 ed.`
A14	`01`			`@1 Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Bologna University Hospital @2 Bologna @3 ITA @Z 1 aut.`
A14	`02`			`@1 Institute of Cellular Medicine Newcastle University and The Newcastle Hospitals NHS Foundation Trust @2 Newcastle @3 GBR @Z 2 aut.`
A14	`03`			`@1 Baylor College of Medicine @2 Houston, Texas @3 USA @Z 3 aut.`
A14	`04`			`@1 Michigan State University, College of Human Medicine @2 Grand Rapids, Michigan @3 USA @Z 4 aut.`
A14	`05`			`@1 Division of Respirology, University of Toronto @2 Toronto @3 CAN @Z 5 aut.`
A14	`06`			`@1 Fu Wai Hospital & National Center for Cardiovascular Disease Peking Union Medical College and Chinese Academy of Medical Science @2 Beijing @3 CHN @Z 6 aut.`
A14	`07`			`@1 Department of Thoracic Surgery, Medical University Vienna/Vienna General Hospital @2 Vienna @3 AUT @Z 7 aut.`
A14	`08`			`@1 Cardiovascular Diseases, Mayo Clinic @2 Rochester, Minnesota @3 USA @Z 8 aut.`
A14	`09`			`@1 Cardiovascular Medicine, The University of Michigan @2 Ann Arbor, Michigan @3 USA @Z 9 aut.`
A14	`10`			`@1 Pulmonary, Critical Care and Sleep Division, Tufts Medical Center, Tufts University School of Medicine @2 Boston, Massachusetts @3 USA @Z 10 aut.`
A14	`11`			`@1 Medical School, University of California, San Diego @2 La Jolla, California @3 USA @Z 11 aut.`
A14	`12`			`@1 Clinical Research, National Institute of Cardiology of Mexico @2 Mexico City @3 MEX @Z 12 aut.`
A14	`13`			`@1 Max Planck Institute for Heart and Lung Research, Universities of Giessen and Marburg Lung Center @2 Giessen/Bad Nauheim @3 DEU @Z 13 aut.`
A14	`14`			`@1 Heart Transplant Unit, St Vincent's Hospital @2 Sydney @3 AUS @Z 14 aut.`
A15	`01`			`@1 Department of Experimental, Diagnostic and Specialty Medicine-DIMES @2 Bologna @3 ITA @Z 1 aut.`
A15	`02`			`@1 Assistance Publique-Hôpitaux de Paris, Service de Pneumologie, Hôpital Universitaire de Bicêtre, Université Paris-Sud, Laboratoire d'excellence en Recherche sur le Médicament et Innovation Thérapeutique, INSERM, Unité 999 @2 Le Kremlin-Bicêtre, Paris @3 FRA @Z 2 aut.`
A20				`@2 D60-D72`
A21				`@1 2013`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20098 @5 354000500747320070`
A44				`@0 0000 @1 © 2014 INIST-CNRS. All rights reserved.`
A45				`@0 86 ref.`
A47	`01`	`1`		`@0 14-0036896`
A60				`@1 P @2 C`
A61				`@0 A`
A64	`01`	`1`		`@0 Journal of the American College of Cardiology`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	@0 The demands on a pulmonary arterial hypertension (PAH) treatment algorithm are multiple and in some ways conflicting. The treatment algorithm usually includes different types of recommendations with varying degrees of scientific evidence. In addition, the algorithm is required to be comprehensive but not too complex, informative yet simple and straightforward. The type of information in the treatment algorithm are heterogeneous including clinical, hemodynamic, medical, interventional, pharmacological and regulatory recommendations. Stakeholders (or users) including physicians from various specialties and with variable expertise in PAH, nurses, patients and patients' associations, healthcare providers, regulatory agencies and industry are often interested in the PAH treatment algorithm for different reasons. These are the considerable challenges faced when proposing appropriate updates to the current evidence-based treatment algorithm. The current treatment algorithm may be divided into 3 main areas: 1) general measures, supportive therapy, referral strategy, acute vasoreactivity testing and chronic treatment with calcium channel blockers; 2) initial therapy with approved PAH drugs; and 3) clinical response to the initial therapy, combination therapy, balloon atrial septostomy, and lung transplantation. All three sections will be revisited highlighting information newly available in the past 5 years and proposing updates where appropriate. The European Society of Cardiology grades of recommendation and levels of evidence will be adopted to rank the proposed treatments.
C02	`01`	`X`		`@0 002B12A`
C02	`02`	`X`		`@0 002B11C`
C03	`01`	`X`	`FRE`	`@0 Hypertension artérielle pulmonaire @5 01`
C03	`01`	`X`	`ENG`	`@0 Pulmonary hypertension @5 01`
C03	`01`	`X`	`SPA`	`@0 Hipertensión arterial pulmonar @5 01`
C03	`02`	`X`	`FRE`	`@0 Pathologie de l'appareil circulatoire @5 02`
C03	`02`	`X`	`ENG`	`@0 Cardiovascular disease @5 02`
C03	`02`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 02`
C03	`03`	`X`	`FRE`	`@0 Traitement @5 09`
C03	`03`	`X`	`ENG`	`@0 Treatment @5 09`
C03	`03`	`X`	`SPA`	`@0 Tratamiento @5 09`
C03	`04`	`X`	`FRE`	`@0 Algorithme @5 10`
C03	`04`	`X`	`ENG`	`@0 Algorithm @5 10`
C03	`04`	`X`	`SPA`	`@0 Algoritmo @5 10`
C03	`05`	`X`	`FRE`	`@0 Arbre décision @5 11`
C03	`05`	`X`	`ENG`	`@0 Decision tree @5 11`
C03	`05`	`X`	`SPA`	`@0 Arbol decisión @5 11`
C03	`06`	`X`	`FRE`	`@0 Artère @5 12`
C03	`06`	`X`	`ENG`	`@0 Artery @5 12`
C03	`06`	`X`	`SPA`	`@0 Arteria @5 12`
C03	`07`	`X`	`FRE`	`@0 Appareil circulatoire @5 13`
C03	`07`	`X`	`ENG`	`@0 Circulatory system @5 13`
C03	`07`	`X`	`SPA`	`@0 Aparato circulatorio @5 13`
C03	`08`	`X`	`FRE`	`@0 Cardiologie @5 14`
C03	`08`	`X`	`ENG`	`@0 Cardiology @5 14`
C03	`08`	`X`	`SPA`	`@0 Cardiología @5 14`
C07	`01`	`X`	`FRE`	`@0 Pathologie de l'appareil respiratoire @5 37`
C07	`01`	`X`	`ENG`	`@0 Respiratory disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Aparato respiratorio patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Vaisseau sanguin @5 38`
C07	`02`	`X`	`ENG`	`@0 Blood vessel @5 38`
C07	`02`	`X`	`SPA`	`@0 Vaso sanguíneo @5 38`
N21				`@1 041`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

A30	`01`	`1`	`ENG`	`@1 WSPH World Symposium on Pulmonary Hypertension @2 5 @3 Nice FRA @4 2013-02-27`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000580

Links to Exploration step

Pascal:14-0036896

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Updated Treatment Algorithm of Pulmonary Arterial Hypertension</title>
<author><name sortKey="Galie, Nazzareno" sort="Galie, Nazzareno" uniqKey="Galie N" first="Nazzareno" last="Galie">Nazzareno Galie</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Bologna University Hospital</s1>
<s2>Bologna</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Corris, Paul A" sort="Corris, Paul A" uniqKey="Corris P" first="Paul A." last="Corris">Paul A. Corris</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute of Cellular Medicine Newcastle University and The Newcastle Hospitals NHS Foundation Trust</s1>
<s2>Newcastle</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Frost, Adaani" sort="Frost, Adaani" uniqKey="Frost A" first="Adaani" last="Frost">Adaani Frost</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Baylor College of Medicine</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Girgis, Reda E" sort="Girgis, Reda E" uniqKey="Girgis R" first="Reda E." last="Girgis">Reda E. Girgis</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Michigan State University, College of Human Medicine</s1>
<s2>Grand Rapids, Michigan</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Granton, John" sort="Granton, John" uniqKey="Granton J" first="John" last="Granton">John Granton</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Division of Respirology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Zhi Cheng Jing" sort="Zhi Cheng Jing" uniqKey="Zhi Cheng Jing" last="Zhi Cheng Jing">ZHI CHENG JING</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Fu Wai Hospital & National Center for Cardiovascular Disease Peking Union Medical College and Chinese Academy of Medical Science</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Klepetko, Walter" sort="Klepetko, Walter" uniqKey="Klepetko W" first="Walter" last="Klepetko">Walter Klepetko</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Thoracic Surgery, Medical University Vienna/Vienna General Hospital</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Autriche</country>
</affiliation>
</author>
<author><name sortKey="Mcgoon, Michael D" sort="Mcgoon, Michael D" uniqKey="Mcgoon M" first="Michael D." last="Mcgoon">Michael D. Mcgoon</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Cardiovascular Diseases, Mayo Clinic</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Mclaughlin, Vallerie V" sort="Mclaughlin, Vallerie V" uniqKey="Mclaughlin V" first="Vallerie V." last="Mclaughlin">Vallerie V. Mclaughlin</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Cardiovascular Medicine, The University of Michigan</s1>
<s2>Ann Arbor, Michigan</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Preston, Ioana R" sort="Preston, Ioana R" uniqKey="Preston I" first="Ioana R." last="Preston">Ioana R. Preston</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Pulmonary, Critical Care and Sleep Division, Tufts Medical Center, Tufts University School of Medicine</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Rubin, Lewis J" sort="Rubin, Lewis J" uniqKey="Rubin L" first="Lewis J." last="Rubin">Lewis J. Rubin</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Medical School, University of California, San Diego</s1>
<s2>La Jolla, California</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Sandoval, Julio" sort="Sandoval, Julio" uniqKey="Sandoval J" first="Julio" last="Sandoval">Julio Sandoval</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Clinical Research, National Institute of Cardiology of Mexico</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Mexique</country>
</affiliation>
</author>
<author><name sortKey="Seeger, Werner" sort="Seeger, Werner" uniqKey="Seeger W" first="Werner" last="Seeger">Werner Seeger</name>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Max Planck Institute for Heart and Lung Research, Universities of Giessen and Marburg Lung Center</s1>
<s2>Giessen/Bad Nauheim</s2>
<s3>DEU</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Keogh, Anne" sort="Keogh, Anne" uniqKey="Keogh A" first="Anne" last="Keogh">Anne Keogh</name>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Heart Transplant Unit, St Vincent's Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">14-0036896</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 14-0036896 INIST</idno>
<idno type="RBID">Pascal:14-0036896</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000580</idno>
<idno type="wicri:Area/PascalFrancis/Curation">005877</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Updated Treatment Algorithm of Pulmonary Arterial Hypertension</title>
<author><name sortKey="Galie, Nazzareno" sort="Galie, Nazzareno" uniqKey="Galie N" first="Nazzareno" last="Galie">Nazzareno Galie</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Bologna University Hospital</s1>
<s2>Bologna</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Corris, Paul A" sort="Corris, Paul A" uniqKey="Corris P" first="Paul A." last="Corris">Paul A. Corris</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Institute of Cellular Medicine Newcastle University and The Newcastle Hospitals NHS Foundation Trust</s1>
<s2>Newcastle</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Frost, Adaani" sort="Frost, Adaani" uniqKey="Frost A" first="Adaani" last="Frost">Adaani Frost</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Baylor College of Medicine</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Girgis, Reda E" sort="Girgis, Reda E" uniqKey="Girgis R" first="Reda E." last="Girgis">Reda E. Girgis</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Michigan State University, College of Human Medicine</s1>
<s2>Grand Rapids, Michigan</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Granton, John" sort="Granton, John" uniqKey="Granton J" first="John" last="Granton">John Granton</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Division of Respirology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Zhi Cheng Jing" sort="Zhi Cheng Jing" uniqKey="Zhi Cheng Jing" last="Zhi Cheng Jing">ZHI CHENG JING</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Fu Wai Hospital & National Center for Cardiovascular Disease Peking Union Medical College and Chinese Academy of Medical Science</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>République populaire de Chine</country>
</affiliation>
</author>
<author><name sortKey="Klepetko, Walter" sort="Klepetko, Walter" uniqKey="Klepetko W" first="Walter" last="Klepetko">Walter Klepetko</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Department of Thoracic Surgery, Medical University Vienna/Vienna General Hospital</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Autriche</country>
</affiliation>
</author>
<author><name sortKey="Mcgoon, Michael D" sort="Mcgoon, Michael D" uniqKey="Mcgoon M" first="Michael D." last="Mcgoon">Michael D. Mcgoon</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Cardiovascular Diseases, Mayo Clinic</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Mclaughlin, Vallerie V" sort="Mclaughlin, Vallerie V" uniqKey="Mclaughlin V" first="Vallerie V." last="Mclaughlin">Vallerie V. Mclaughlin</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Cardiovascular Medicine, The University of Michigan</s1>
<s2>Ann Arbor, Michigan</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Preston, Ioana R" sort="Preston, Ioana R" uniqKey="Preston I" first="Ioana R." last="Preston">Ioana R. Preston</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Pulmonary, Critical Care and Sleep Division, Tufts Medical Center, Tufts University School of Medicine</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Rubin, Lewis J" sort="Rubin, Lewis J" uniqKey="Rubin L" first="Lewis J." last="Rubin">Lewis J. Rubin</name>
<affiliation wicri:level="1"><inist:fA14 i1="11"><s1>Medical School, University of California, San Diego</s1>
<s2>La Jolla, California</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Sandoval, Julio" sort="Sandoval, Julio" uniqKey="Sandoval J" first="Julio" last="Sandoval">Julio Sandoval</name>
<affiliation wicri:level="1"><inist:fA14 i1="12"><s1>Clinical Research, National Institute of Cardiology of Mexico</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>Mexique</country>
</affiliation>
</author>
<author><name sortKey="Seeger, Werner" sort="Seeger, Werner" uniqKey="Seeger W" first="Werner" last="Seeger">Werner Seeger</name>
<affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Max Planck Institute for Heart and Lung Research, Universities of Giessen and Marburg Lung Center</s1>
<s2>Giessen/Bad Nauheim</s2>
<s3>DEU</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Keogh, Anne" sort="Keogh, Anne" uniqKey="Keogh A" first="Anne" last="Keogh">Anne Keogh</name>
<affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Heart Transplant Unit, St Vincent's Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>14 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Journal of the American College of Cardiology</title>
<title level="j" type="abbreviated">J. Am. Coll. Cardiol.</title>
<idno type="ISSN">0735-1097</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Journal of the American College of Cardiology</title>
<title level="j" type="abbreviated">J. Am. Coll. Cardiol.</title>
<idno type="ISSN">0735-1097</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Algorithm</term>
<term>Artery</term>
<term>Cardiology</term>
<term>Cardiovascular disease</term>
<term>Circulatory system</term>
<term>Decision tree</term>
<term>Pulmonary hypertension</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Hypertension artérielle pulmonaire</term>
<term>Pathologie de l'appareil circulatoire</term>
<term>Traitement</term>
<term>Algorithme</term>
<term>Arbre décision</term>
<term>Artère</term>
<term>Appareil circulatoire</term>
<term>Cardiologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The demands on a pulmonary arterial hypertension (PAH) treatment algorithm are multiple and in some ways conflicting. The treatment algorithm usually includes different types of recommendations with varying degrees of scientific evidence. In addition, the algorithm is required to be comprehensive but not too complex, informative yet simple and straightforward. The type of information in the treatment algorithm are heterogeneous including clinical, hemodynamic, medical, interventional, pharmacological and regulatory recommendations. Stakeholders (or users) including physicians from various specialties and with variable expertise in PAH, nurses, patients and patients' associations, healthcare providers, regulatory agencies and industry are often interested in the PAH treatment algorithm for different reasons. These are the considerable challenges faced when proposing appropriate updates to the current evidence-based treatment algorithm. The current treatment algorithm may be divided into 3 main areas: 1) general measures, supportive therapy, referral strategy, acute vasoreactivity testing and chronic treatment with calcium channel blockers; 2) initial therapy with approved PAH drugs; and 3) clinical response to the initial therapy, combination therapy, balloon atrial septostomy, and lung transplantation. All three sections will be revisited highlighting information newly available in the past 5 years and proposing updates where appropriate. The European Society of Cardiology grades of recommendation and levels of evidence will be adopted to rank the proposed treatments.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0735-1097</s0>
</fA01>
<fA02 i1="01"><s0>JACCDI</s0>
</fA02>
<fA03 i2="1"><s0>J. Am. Coll. Cardiol.</s0>
</fA03>
<fA05><s2>62</s2>
</fA05>
<fA06><s2>25</s2>
<s3>SUPD</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Updated Treatment Algorithm of Pulmonary Arterial Hypertension</s1>
</fA08>
<fA09 i1="01" i2="1" l="ENG"><s1>Updates in Pulmonary Hypertension: Proceedings of the 5th World Symposium on Pulmonary Hypertension</s1>
</fA09>
<fA11 i1="01" i2="1"><s1>GALIE (Nazzareno)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>CORRIS (Paul A.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>FROST (Adaani)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>GIRGIS (Reda E.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>GRANTON (John)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>ZHI CHENG JING</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>KLEPETKO (Walter)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>MCGOON (Michael D.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>MCLAUGHLIN (Vallerie V.)</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>PRESTON (Ioana R.)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>RUBIN (Lewis J.)</s1>
</fA11>
<fA11 i1="12" i2="1"><s1>SANDOVAL (Julio)</s1>
</fA11>
<fA11 i1="13" i2="1"><s1>SEEGER (Werner)</s1>
</fA11>
<fA11 i1="14" i2="1"><s1>KEOGH (Anne)</s1>
</fA11>
<fA12 i1="01" i2="1"><s1>GALIE (Nazzareno)</s1>
<s9>ed.</s9>
</fA12>
<fA12 i1="02" i2="1"><s1>SIMONNEAU (Gerald)</s1>
<s9>ed.</s9>
</fA12>
<fA14 i1="01"><s1>Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Bologna University Hospital</s1>
<s2>Bologna</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Institute of Cellular Medicine Newcastle University and The Newcastle Hospitals NHS Foundation Trust</s1>
<s2>Newcastle</s2>
<s3>GBR</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Baylor College of Medicine</s1>
<s2>Houston, Texas</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Michigan State University, College of Human Medicine</s1>
<s2>Grand Rapids, Michigan</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Division of Respirology, University of Toronto</s1>
<s2>Toronto</s2>
<s3>CAN</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Fu Wai Hospital & National Center for Cardiovascular Disease Peking Union Medical College and Chinese Academy of Medical Science</s1>
<s2>Beijing</s2>
<s3>CHN</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Department of Thoracic Surgery, Medical University Vienna/Vienna General Hospital</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Cardiovascular Diseases, Mayo Clinic</s1>
<s2>Rochester, Minnesota</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Cardiovascular Medicine, The University of Michigan</s1>
<s2>Ann Arbor, Michigan</s2>
<s3>USA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="10"><s1>Pulmonary, Critical Care and Sleep Division, Tufts Medical Center, Tufts University School of Medicine</s1>
<s2>Boston, Massachusetts</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="11"><s1>Medical School, University of California, San Diego</s1>
<s2>La Jolla, California</s2>
<s3>USA</s3>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="12"><s1>Clinical Research, National Institute of Cardiology of Mexico</s1>
<s2>Mexico City</s2>
<s3>MEX</s3>
<sZ>12 aut.</sZ>
</fA14>
<fA14 i1="13"><s1>Max Planck Institute for Heart and Lung Research, Universities of Giessen and Marburg Lung Center</s1>
<s2>Giessen/Bad Nauheim</s2>
<s3>DEU</s3>
<sZ>13 aut.</sZ>
</fA14>
<fA14 i1="14"><s1>Heart Transplant Unit, St Vincent's Hospital</s1>
<s2>Sydney</s2>
<s3>AUS</s3>
<sZ>14 aut.</sZ>
</fA14>
<fA15 i1="01"><s1>Department of Experimental, Diagnostic and Specialty Medicine-DIMES</s1>
<s2>Bologna</s2>
<s3>ITA</s3>
<sZ>1 aut.</sZ>
</fA15>
<fA15 i1="02"><s1>Assistance Publique-Hôpitaux de Paris, Service de Pneumologie, Hôpital Universitaire de Bicêtre, Université Paris-Sud, Laboratoire d'excellence en Recherche sur le Médicament et Innovation Thérapeutique, INSERM, Unité 999</s1>
<s2>Le Kremlin-Bicêtre, Paris</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
</fA15>
<fA20><s2>D60-D72</s2>
</fA20>
<fA21><s1>2013</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20098</s2>
<s5>354000500747320070</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2014 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>86 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>14-0036896</s0>
</fA47>
<fA60><s1>P</s1>
<s2>C</s2>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Journal of the American College of Cardiology</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The demands on a pulmonary arterial hypertension (PAH) treatment algorithm are multiple and in some ways conflicting. The treatment algorithm usually includes different types of recommendations with varying degrees of scientific evidence. In addition, the algorithm is required to be comprehensive but not too complex, informative yet simple and straightforward. The type of information in the treatment algorithm are heterogeneous including clinical, hemodynamic, medical, interventional, pharmacological and regulatory recommendations. Stakeholders (or users) including physicians from various specialties and with variable expertise in PAH, nurses, patients and patients' associations, healthcare providers, regulatory agencies and industry are often interested in the PAH treatment algorithm for different reasons. These are the considerable challenges faced when proposing appropriate updates to the current evidence-based treatment algorithm. The current treatment algorithm may be divided into 3 main areas: 1) general measures, supportive therapy, referral strategy, acute vasoreactivity testing and chronic treatment with calcium channel blockers; 2) initial therapy with approved PAH drugs; and 3) clinical response to the initial therapy, combination therapy, balloon atrial septostomy, and lung transplantation. All three sections will be revisited highlighting information newly available in the past 5 years and proposing updates where appropriate. The European Society of Cardiology grades of recommendation and levels of evidence will be adopted to rank the proposed treatments.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B12A</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B11C</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Hypertension artérielle pulmonaire</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Pulmonary hypertension</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Hipertensión arterial pulmonar</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Pathologie de l'appareil circulatoire</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Traitement</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Treatment</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Tratamiento</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Algorithme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Algorithm</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Algoritmo</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Arbre décision</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Decision tree</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Arbol decisión</s0>
<s5>11</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Artère</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Artery</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Arteria</s0>
<s5>12</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Appareil circulatoire</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Circulatory system</s0>
<s5>13</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Aparato circulatorio</s0>
<s5>13</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Cardiologie</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Cardiology</s0>
<s5>14</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Cardiología</s0>
<s5>14</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'appareil respiratoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Respiratory disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato respiratorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Vaisseau sanguin</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Blood vessel</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Vaso sanguíneo</s0>
<s5>38</s5>
</fC07>
<fN21><s1>041</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
<pR><fA30 i1="01" i2="1" l="ENG"><s1>WSPH World Symposium on Pulmonary Hypertension</s1>
<s2>5</s2>
<s3>Nice FRA</s3>
<s4>2013-02-27</s4>
</fA30>
</pR>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005877 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 005877 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:14-0036896
   |texte=   Updated Treatment Algorithm of Pulmonary Arterial Hypertension
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Updated Treatment Algorithm of Pulmonary Arterial Hypertension

Updated Treatment Algorithm of Pulmonary Arterial Hypertension

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri